Abstract
Lateral pelvic lymph node (LPLN) involvement occurs in 10%–25% of rectal cancer cases. Total mesorectal excision (TME) with routine LPLN dissection (LPLND) is predominantly applied in Japan whereas TME with neoadjuvant treatment are used in the West. LPLND is a morbid procedure and minimally invasive techniques may help reduce its morbidity. Selective lateral pelvic node dissection with TME following neoadjuvant treatment achieves acceptable disease-free and overall survival.
Original language | English (US) |
---|---|
Pages (from-to) | 1264-1270 |
Number of pages | 7 |
Journal | Journal of Surgical Oncology |
Volume | 127 |
Issue number | 8 |
DOIs | |
State | Published - Jun 15 2023 |
Externally published | Yes |
Keywords
- lateral pelvic lymph nodes
- pelvic lymphadenopathy
- rectal adenocarcinoma
- rectal cancer
ASJC Scopus subject areas
- Surgery
- Oncology